Temat: "Glycation End Products" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Study of the mechanism by gentiopicroside protects against skin fibroblast glycation damage via the RAGE pathway.
Autorzy:: Chen C; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Liu X; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Li L; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Guo M; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
He Y; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Dong Y; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Meng H; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
Yi F; Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China. .; The School of Light Industry Science and Technology, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 26; Vol. 14 (1), pp. 4685. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Glycation End Products, Advanced*/metabolism
Maillard Reaction*
Iridoid Glucosides*
Receptor for Advanced Glycation End Products/metabolism ; NF-kappa B/metabolism ; Oxidative Stress ; Fibroblasts/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study.
Autorzy:: Tayyib NA; Vice Deanship, Postgraduate Research and Scientific Studies, Faculty of Nursing, Umm Al-Qura University, Makkah, Saudi Arabia.
Ramaiah P; Faculty of Nursing, Umm al- Qura University, Makkah, Saudi Arabia. .
Alshahrani SH; Medical Surgical Nursing Department, King Khalid University, Khamis Mushate, Saudi Arabia.
Margiana R; Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.; Master's Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.; Andrology Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Almalki SG; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, 11952, Saudi Arabia.
Kareem AK; Biomedical Engineering Department, Al-Mustaqbal University College, Babylon, Iraq.
Zabibah RS; Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.
Shbeer AM; Department of Surgery, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Ali SHJ; Department of medical laboratory, College of Health and Medical Technololgy, Al-Ayen University, Thi-Qar, Iraq.
Mustafa YF; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq.; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2023 Dec 15; Vol. 23 (1), pp. 275. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Obesity*
Glycation End Products, Advanced*
Adult ; Humans ; Middle Aged ; Receptor for Advanced Glycation End Products ; Cross-Sectional Studies ; Body Mass Index ; Weight Loss

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.
Autorzy:: Leung SS; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; School of Medicine and Dentistry, Griffith University, Brisbane, Australia.; Wesley Research Institute, The Wesley Hospital, Brisbane, Australia.
Lenchik N; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Mathews C; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Pugliese A; Division of Endocrinology, Department of Microbiology and Immunology, Department of Medicine, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
McCarthy DA; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Le Bagge S; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Ewing A; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Translational Bioinformatics Group, MRI-UQ, TRI, Brisbane, Australia.
Harris M; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Queensland Diabetes Centre, Mater Health Services, Brisbane, Australia.
Radford KJ; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Cancer Immunotherapies Group, MRI-UQ, TRI, Brisbane, Australia.
Borg DJ; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Gerling I; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Forbes JM; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia. .; Faculty of Medicine, The University of Queensland, Brisbane, Australia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12948. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 1*/genetics
Glucagon-Secreting Cells*/metabolism
Hypoglycemia*
Receptor for Advanced Glycation End Products*/metabolism
Adolescent ; Humans ; Glucagon ; Glycation End Products, Advanced/metabolism ; Ligands

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: A Role for Advanced Glycation End Products in Molecular Ageing.
Autorzy:: Zgutka K; Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University, Żołnierska 54, 70-210 Szczecin, Poland.
Tkacz M; Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University, Żołnierska 54, 70-210 Szczecin, Poland.
Tomasiak P; Institute of Physical Culture Sciences, University of Szczecin, 70-453 Szczecin, Poland.
Tarnowski M; Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University, Żołnierska 54, 70-210 Szczecin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 08; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Glycation End Products, Advanced*/metabolism
Diabetes Mellitus*
Humans ; Aging/metabolism ; Chronic Disease ; Receptor for Advanced Glycation End Products/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Effects of advanced glycation end products (AGEs) on the differentiation potential of primary stem cells: a systematic review.
Autorzy:: Xu K; Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Zhang L; Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Yu N; Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Ren Z; Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Wang T; Department of Traumatology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Zhang Y; Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Zhao X; Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. .
Yu T; Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2023 Apr 11; Vol. 14 (1), pp. 74. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:: Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Glycation End Products, Advanced*/pharmacology
Glycation End Products, Advanced*/metabolism
Diabetes Mellitus*/metabolism
Humans ; Receptor for Advanced Glycation End Products ; Stem Cells/metabolism ; Cell Differentiation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: RAGE-TLR4 Crosstalk Is the Key Mechanism by Which High Glucose Enhances the Lipopolysaccharide-Induced Inflammatory Response in Primary Bovine Alveolar Macrophages.
Autorzy:: Yan L; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Li Y; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Tan T; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Qi J; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Fang J; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Guo H; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Ren Z; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Gou L; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Geng Y; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Cui H; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Shen L; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Yu S; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.
Wang Z; Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611134, China.
Zuo Z; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 10; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: NF-kappa B*/metabolism
Toll-Like Receptor 4*/genetics
Toll-Like Receptor 4*/metabolism
Receptor for Advanced Glycation End Products*/metabolism
Animals ; Cattle ; Cytokines/metabolism ; Glucose ; Glycation End Products, Advanced ; Interleukin-6/metabolism ; Lipopolysaccharides/toxicity ; Macrophages, Alveolar/metabolism ; Myeloid Differentiation Factor 88/genetics ; Myeloid Differentiation Factor 88/metabolism ; RNA, Messenger ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Concentrations of N -Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients.
Autorzy:: Damasiewicz-Bodzek A; Department of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Nowak A; Department of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2022 Dec 13; Vol. 12 (12). Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Psoriasis*/blood
Psoriasis*/metabolism
Receptor for Advanced Glycation End Products*/blood
Receptor for Advanced Glycation End Products*/metabolism
Humans ; Glycation End Products, Advanced/metabolism ; Maillard Reaction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products.
Autorzy:: Li L; Endocrine and Metabolic Diseases Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250001, China.
Song Q; Department of Pharmacy, Linyi People's Hospital, Linyi 276000, China.
Zhang X; Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250118, China.
Yan Y; Department of Surgery, Qilu Hospital of Shandong University, Jinan 250012, China.
Wang X; Endocrine and Metabolic Diseases Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250001, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2022 Dec 12; Vol. 27 (24). Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:: Journal Article
MeSH Terms:: Glycation End Products, Advanced*/metabolism
Diabetes Mellitus, Experimental*/metabolism
Rats ; Animals ; Receptor for Advanced Glycation End Products/metabolism ; Rats, Wistar ; Oxidative Stress

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
Autorzy:: Sakai-Sakasai A; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku 920-0293, Ishikawa, Japan.; General Medicine Center, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Kahoku 920-0293, Ishikawa, Japan.
Takeda K; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku 920-0293, Ishikawa, Japan.; Department of Cardiology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku 920-0293, Ishikawa, Japan.
Suzuki H; Department of Organic and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa 920-1181, Ishikawa, Japan.
Takeuchi M; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku 920-0293, Ishikawa, Japan.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Feb 08; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Glycation End Products, Advanced*/metabolism
Glyceraldehyde*/metabolism
Animals ; Sugars ; Maillard Reaction ; Mammals/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.
Autorzy:: Faruqui T; Department of Biosciences, Integral University, Dasauli, P.O. Basha, Kursi Road, Lucknow 226026, Uttar Pradesh, India.
Khan MS; Department of Biochemistry, Aligarh Muslim University, Aligarh 202002, Uttar Pradesh, India.
Akhter Y; Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, Uttar Pradesh, India.
Khan S; Department of Biosciences, Integral University, Dasauli, P.O. Basha, Kursi Road, Lucknow 226026, Uttar Pradesh, India.
Rafi Z; Department of Biosciences, Integral University, Dasauli, P.O. Basha, Kursi Road, Lucknow 226026, Uttar Pradesh, India.
Saeed M; Plasma Bioscience Research Center, Applied Plasma Medicine Center, Department of Electrical & Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
Han I; Department of Biology, College of Sciences, University of Hail, Hail P.O. Box 2240, Saudi Arabia.
Choi EH; Department of Biology, College of Sciences, University of Hail, Hail P.O. Box 2240, Saudi Arabia.
Yadav DK; Gachon Institute of Pharmaceutical Science and Department of Pharmacy, College of Pharmacy, Gachon University, Hambakmoeiro 191, Yeonsu-gu, Incheon 21924, Republic of Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 23; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplasms*/drug therapy
Receptor for Advanced Glycation End Products*/antagonists & inhibitors
Humans ; Glycation End Products, Advanced/metabolism ; Inflammation/metabolism ; Ligands

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
Autorzy:: Liu W; Department of Cardiology, Xi'an First Hospital, Xi'an 710002, China.
Ji Y; Central Laboratory, Xi'an First Hospital, Xi'an 710002, China.
Zhang W; Xi'an First Hospital, Xi'an 710002, China.
Fang F; Central Laboratory, Xi'an First Hospital, Xi'an 710002, China.
Cai Q; Department of Cardiology, Xi'an First Hospital, Xi'an 710002, China.
Li Y; Department of Cardiology, Xi'an First Hospital, Xi'an 710002, China.; Pokaż więcej
Źródło:: Computational intelligence and neuroscience [Comput Intell Neurosci] 2022 Jun 10; Vol. 2022, pp. 8970860. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).
Typ publikacji:: Journal Article; Retracted Publication
MeSH Terms:: Atherosclerosis*/diagnosis
Atherosclerosis*/metabolism
Atherosclerosis*/pathology
Coronary Disease*/diagnosis
Coronary Disease*/metabolism
Coronary Disease*/pathology
Receptor for Advanced Glycation End Products*/blood
Receptor for Advanced Glycation End Products*/metabolism
Lysine/*analogs & derivatives
Biomarkers ; Glycation End Products, Advanced ; Humans ; Lysine/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy?
Autorzy:: Kurashima CK; School of Natural Sciences and Mathematics, Chaminade University of Honolulu, Honolulu, HI 96816, USA.
Ng PK; School of Natural Sciences and Mathematics, Chaminade University of Honolulu, Honolulu, HI 96816, USA.
Kendal-Wright CE; School of Natural Sciences and Mathematics, Chaminade University of Honolulu, Honolulu, HI 96816, USA.; Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.; Department of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Jun 07; Vol. 23 (12). Date of Electronic Publication: 2022 Jun 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: COVID-19*
Glycation End Products, Advanced*/metabolism
Carrier Proteins ; Female ; Humans ; NF-kappa B/metabolism ; Pregnancy ; Receptor for Advanced Glycation End Products/metabolism ; Receptors, Immunologic/metabolism ; SARS-CoV-2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A Novel Approach: Investigating the Intracellular Clearance Mechanism of Glyceraldehyde-Derived Advanced Glycation End-Products Using the Artificial Checkpoint Kinase 1 d270KD Mutant as a Substrate Model.
Autorzy:: Takeda K; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Ishikawa 920-0293, Japan.; Department of Cardiology, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Ishikawa 920-0293, Japan.
Sakai-Sakasai A; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Ishikawa 920-0293, Japan.
Kajinami K; Department of Cardiology, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Ishikawa 920-0293, Japan.
Takeuchi M; Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Ishikawa 920-0293, Japan.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Dec 14; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Glycation End Products, Advanced*/metabolism
Glyceraldehyde*
Proteasome Endopeptidase Complex ; Checkpoint Kinase 1 ; Maillard Reaction ; Ubiquitins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Receptor for advanced glycation end products aggravates cognitive deficits in type 2 diabetes through binding of C-terminal AAs 2-5 to mitogen-activated protein kinase kinase 3 (MKK3) and facilitation of MEKK3-MKK3-p38 module assembly.
Autorzy:: Zhou XY; Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.; Department of Genetics, Xuzhou Engineering Research Center of Medical Genetics and Transformation, Xuzhou Medical University, Xuzhou, China.
Ying CJ; Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Hu B; Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
Zhang YS; The Graduate School, Xuzhou Medical University, Xuzhou, China.
Gan T; The Graduate School, Xuzhou Medical University, Xuzhou, China.
Zhu YD; The Graduate School, Xuzhou Medical University, Xuzhou, China.
Wang N; Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
Li AA; Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
Song YJ; Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.; Department of Genetics, Xuzhou Engineering Research Center of Medical Genetics and Transformation, Xuzhou Medical University, Xuzhou, China.; Pokaż więcej
Źródło:: Aging cell [Aging Cell] 2022 Feb; Vol. 21 (2), pp. e13543. Date of Electronic Publication: 2022 Jan 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Experimental*/metabolism
Diabetes Mellitus, Type 2*/metabolism
MAP Kinase Kinase 3*/genetics
MAP Kinase Kinase 3*/metabolism
MAP Kinase Kinase Kinase 3*/metabolism
Receptor for Advanced Glycation End Products*/metabolism
p38 Mitogen-Activated Protein Kinases*/metabolism
Animals ; Cognition ; Glycation End Products, Advanced/metabolism ; Mice

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Antiglycoxidative properties of amantadine - a systematic review and comprehensive in vitro study.
Autorzy:: Nesterowicz M; Students' Scientific Club 'Biochemistry of Civilization Diseases' at the Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Białystok, Poland.
Żendzian-Piotrowska M; Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Białystok, Poland.
Ładny JR; 1st Department of General Surgery and Endocrinology, Medical University of Bialystok, Białystok, Poland.
Zalewska A; Independent Laboratory of Experimental Dentistry, Medical University of Bialystok, Białystok, Poland.
Maciejczyk M; Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Białystok, Poland.; Pokaż więcej
Źródło:: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 138-155.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Antioxidants*/chemistry
Glycation End Products, Advanced*
Molecular Docking Simulation ; Serum Albumin, Bovine/chemistry ; Amantadine/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications.
Autorzy:: Ramasamy R; Diabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Shekhtman A; Department of Chemistry, The State University of New York at Albany, Albany, NY 12222, USA.
Schmidt AM; Diabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Apr 21; Vol. 23 (9). Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Diabetes Complications*/metabolism
Formins*/metabolism
Receptor for Advanced Glycation End Products*/metabolism
Carrier Proteins/metabolism ; Diabetes Mellitus, Type 2/complications ; Glycation End Products, Advanced/metabolism ; Humans ; Ligands ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
Autorzy:: Malik P; School of Chemical Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India.
Hoidal JR; Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah, USA.; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Mukherjee TK; Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah, USA.; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.; Pokaż więcej
Źródło:: COPD [COPD] 2021 Dec; Vol. 18 (6), pp. 737-748. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pulmonary Disease, Chronic Obstructive*/complications
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/genetics
Pulmonary Emphysema*
Receptor for Advanced Glycation End Products*/genetics
Receptor for Advanced Glycation End Products*/therapeutic use
Animals ; Glycation End Products, Advanced/metabolism ; Humans ; Lung ; Mammals

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Hemodialysis Patients with Higher Serum Levels of Soluble Receptor for Advanced Glycation End Products Have an Increased Risk for Arteriovenous Fistula Failure.
Autorzy:: Ticala M; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Rusu CC; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Moldovan D; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Potra AR; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Tirinescu DC; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Coman AL; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Bondor CI; Department of Informatics and Biostatistics, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.
Budisan L; Research Center for Functional Genomic, Biomedicine and Translational Medicine, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj Napoca, Romania.
Kacsó IM; Department of Nephrology, University of Medicine and Pharmacy 'Iuliu Hațieganu', Cluj-Napoca, Romania.; Pokaż więcej
Źródło:: Blood purification [Blood Purif] 2022; Vol. 51 (9), pp. 764-771. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji:: Journal Article
MeSH Terms:: Arteriovenous Fistula*
Glycation End Products, Advanced*
Biomarkers ; Constriction, Pathologic ; Humans ; Receptor for Advanced Glycation End Products ; Renal Dialysis/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Comprehensive Analyses of Advanced Glycation end Products and Heterocyclic Amines in Peanuts during the Roasting Process.
Autorzy:: Yu J; Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou 450001, China.
Yu X; College of Food Science and Technology, Henan University of Technology, Lianhua Street, Zhengzhou 450001, China.
Shi L; College of Food Science and Technology, Henan University of Technology, Lianhua Street, Zhengzhou 450001, China.
Liu W; College of Food Science and Technology, Henan University of Technology, Lianhua Street, Zhengzhou 450001, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Oct 10; Vol. 28 (20). Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:: Journal Article
MeSH Terms:: Arachis*
Glycation End Products, Advanced*/analysis
Lysine/analysis ; Magnesium Oxide ; Amines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer.
Autorzy:: Rossi GR; SIWA Therapeutics Inc., Chicago, IL, 60601, USA.
Jensen A; Molecular Medicine Division, Translational Genomics Research Institute, Part of City of Hope, 445 N. Fifth St., Phoenix, AZ, 85004, USA.
Ng S; Molecular Medicine Division, Translational Genomics Research Institute, Part of City of Hope, 445 N. Fifth St., Phoenix, AZ, 85004, USA.
Yin Z; Molecular Anatomical Pathology Cores & Biobanking Shared Resources, City of Hope, Duarte, CA, 91010, USA.
Li A; Molecular Anatomical Pathology Cores & Biobanking Shared Resources, City of Hope, Duarte, CA, 91010, USA.
Misra A; Molecular Anatomical Pathology Cores & Biobanking Shared Resources, City of Hope, Duarte, CA, 91010, USA.
Von Hoff DD; Molecular Medicine Division, Translational Genomics Research Institute, Part of City of Hope, 445 N. Fifth St., Phoenix, AZ, 85004, USA.
Gruber L; SIWA Therapeutics Inc., Chicago, IL, 60601, USA.
Gruber M; SIWA Therapeutics Inc., Chicago, IL, 60601, USA.
Han H; Molecular Medicine Division, Translational Genomics Research Institute, Part of City of Hope, 445 N. Fifth St., Phoenix, AZ, 85004, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 07; Vol. 13 (1), pp. 16953. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Glycation End Products, Advanced*
Pancreatic Neoplasms*/pathology
Humans ; Mice ; Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Biomarkers ; Xenograft Model Antitumor Assays ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Glycation End Products"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji